Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEBATER 2 acute coronary syndrome PCI trial
2010-023779-24Phase 4Active
- Sponsor
- Toegepast Cardiologisch Onderzoek
- Start
- Nov 2010
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bivalirudin in acute coronary syndrome (ACS) (4 arms), sponsored by Toegepast Cardiologisch Onderzoek. Primary endpoints: Primary composite endpoint, Primary endpoint for stent comparison and 1 more. Started Nov 2010; status: active.
02
Drugs
bivalirudin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on 2010-023779-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023779-24.